Rubicon Research IPO listing date is scheduled for tomorrow (Thursday, October 16). Rubicon Research IPO award was finalized yesterday (Tuesday, October 14). For those granted shares, the creditworthiness of shares to Dematriges will take place today, Wednesday, October 15. The process of paying those who have not yet received their shares will also be completed today. The pharmaceutical company Rubicon Research has launched its IPO for subscription from Thursday, October 9 to Monday, October 13. With the closing of the bid period, the offer received a healthy response, especially from non-institutional investors (NIIs) who signed up at 130,26 times 97.61 times, followed by qualified institutional buyers (QIBs). Retail investors showed a 35.47 -time subscription rate. On the third day of the IPO, the Rubicon Research IPO subscription status stood at 103.90 times, as reported by the BSE. Rubicon Research IPO has reserved no less than 75% of the shares in the public issue for qualified institutional buyers (QIB), no more than 15% for Institutional Investors (NII), and no more than 10% of the offer is reserved for retail investors. Rubicon Research IPO Price Band is determined in the vicinity of £ 461 to £ 485 per equity share of the face value of re 1. The outreach size is 30 shares and in multiples of 30 shares. Let’s see what Rubicon IPO GMP is ahead of the list today. Rubicon Research IPO GMP Today Rubicon Research IPO GMP Today or Gray Market Premium is £ 143. This indicates that the price of Rubicon Research traded at a £ 143 premium in the Gray Market on Wednesday, according to Investorgain.com. Taking into account the top of the IPO price band and the current premium in the Gray market, the estimated list price of Rubicon Research share price is indicated at £ 628 each, which is 29.48% higher than the £ 485 IPO price. listing ahead. The minimum GMP recorded is £ 0.00, while the maximum GMP stands at £ 143 according to analysts. ‘Gray Market Premium’ indicates investors’ readiness to pay more than the issue price. Rubicon Research IPO Details The Rubicon IPO contains a new issue of shares for £ 500 shares and a share offer-for-sell (OFS) worth £ 877.5 from the promoter, the general Atlantic Singapore RR PTE Ltd. The yield of £ 310 crore of the new issue will become debt repayment, while a portion will be aimed at facilating the growing. through acquisitions, strategic initiatives and general corporate purposes. JM Financial, Axis Capital, IIFL Capital, SBI Capital Markets, and MUFG INGIGE INDIA PVT. Ltd. act as the registrar for the offer. Rubicon Research Ipo Disclaimer: The views and recommendations above are those of individual analysts or brokerage businesses, and not of currency. We advise investors to check with certified experts before making investment decisions.
Rubicon Research IPO list tomorrow: Here’s what GMP, subscription status tip before debut
